Stock ALVIO VALERIO THERAPEUTICS
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Valerio Therapeutics

Equities

ALVIO

FR0010095596

Market Closed - Euronext Paris
Other stock markets
 09:05:25 26/04/2024 pm IST 		5-day change 1st Jan Change
0.11 EUR -2.65% Intraday chart for Valerio Therapeutics -6.78% -33.33%
2023 Valerio Therapeutics Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2023 CI
2023 Onxeo SA has Changed its Name to Valerio Therapeutics CI

Evolution of the average Target Price on Valerio Therapeutics

Price target over the last 5 years

History of analyst recommendation changes

4a9b4.xEpwxbsnrT87IIkPLXiPoAfvE84AIPMln_Zgu2AHJa8.oCAfmtRM5VlBbfF1GDLi8nG9Wv9XUd5LqrgmiAcyEcD2Eynw7BbZBgIQ7g~13c692b2d7258b7b13c97cd7ec3705aa

Analyst Recommendations on Valerio Therapeutics

Onxeo : Bryan Garnier & Co initiates the coverage of Onxeo with a “Buy” recommendation PU
Bryan Garnier & Co Initiates Coverage of Onxeo with a “Buy” Recommendation GL
Onxeo : Bryan Garnier & Co Initiates the Coverage of Onxeo with a “Buy” Recommendation BU
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.11 EUR
Average target price
1.2 EUR
Spread / Average Target
+990.91%
High Price Target
1.2 EUR
Spread / Highest target
+990.91%
Low Price Target
1.2 EUR
Spread / Lowest Target
+990.91%

Consensus detail

Consensus revision (last 18 months)

Annual profits - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. ALVIO Stock
  4. Consensus Valerio Therapeutics